Population Health
The absence of more stores like CVS that are easily accessible to people in impoverished, predominantly black neighborhoods underscores Baltimore's other persistent inequities.
While there are currently only 22 proton therapy centers in the United States, the growing interest in the advanced cancer therapy is causing more hospitals to weigh the benefits against the high cost of opening their own centers.
Nearly half of the nation's academic medical centers are being punished through one of the federal government's sternest attempts to promote patient safety.
Nicole Lamoureux, CEO of the National Association of Free and Charitable Clinics, said in many states these organizations are expanding their mission to make sure they can serve the underinsured-people who have coverage but whose premium and deductible represents 10 percent or more of their income.
In states that expanded Medicaid under the Affordable Care Act, low-income adults were more likely to see a doctor, stay overnight in a hospital and receive their first diagnoses of diabetes and high cholesterol, according to a study published Monday.
The number of potentially deadly infections from contaminated medical scopes is far higher than what federal officials previously estimated, a new congressional investigation shows.
On the reservation, IHS facilities often don't have services that people elsewhere expect, such as emergency departments or MRI machines. And those limited facilities can be hours away by car. Clinics also don't have enough funding to meet all of the health needs of the community. And people can't get the free drugs they are entitled to through the IHS anywhere but an IHS facility.
A collaboration between scientists, clinicians and industry partners, the institute will spearhead efforts in cancer immunotherapy research -- benefitting from what amounts to the largest single contribution ever made to the field.
He spoke to our sister site Healthcare IT News about the program, the people who make Geisinger work, the evolution of population health and the promise of what he calls "anticipatory medicine."
The first Zika vaccine candidate may enter initial clinical trials in September, the director of the U.S. National Institute of Allergy and Infectious Diseases said.